Hudson Frederick M.

CIK 00014384624 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001438462

Recent Transactions

50 trades

Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2026-01-09$12.98/sh+15,000→ 61,307 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2026-01-09−15,000→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−6,124→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−30,000→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−19,750→ 0 total
Disposition to Issuer
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-10-07−16,300→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-08-14$42.26/sh−7,457→ 46,307 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2025-06-03+30,000→ 30,000 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-02-22+5,369→ 53,764 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2025-02-22−5,369→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2025-02-19+4,475→ 4,475 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2025-02-19+7,296→ 7,296 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2025-01-22−20,000→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2025-01-22$9.13/sh+20,000→ 48,395 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-11-08$36.28/sh−8,722→ 28,395 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2024-06-11+19,750→ 19,750 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2024-02-23+3,886→ 37,117 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Unit
2024-02-23−3,886→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2024-02-22+8,252→ 8,252 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2024-02-22+5,369→ 5,369 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-11-15$28.50/sh−5,211→ 33,231 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2023-11-15−7,457→ 0 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-11-15$28.50/sh−3,882→ 38,442 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-11-15$9.24/sh+7,457→ 42,324 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2023-06-06+17,300→ 17,300 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2023-02-23+6,293→ 6,293 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-23+3,886→ 3,886 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-02-22+3,882→ 34,867 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2023-02-22−3,882→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2023-01-10$7.90/sh+8,722→ 30,985 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2023-01-10−8,722→ 0 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2022-06-14+16,300→ 16,300 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-22+3,882→ 3,882 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2022-02-22+6,847→ 6,847 total
Disposition to Issuer
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2022-02-19−4,222→ 0 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2022-02-19+4,222→ 22,263 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2021-06-08+16,300→ 16,300 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Restricted Stock Units
2021-02-19+4,222→ 4,222 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2021-02-19+7,365→ 7,365 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2020-07-13−8,750→ 0 total
Exercise/Conversion
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-07-13$2.56/sh+8,750→ 18,961 total
Sale
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-07-13$24.44/sh−920→ 18,041 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2020-06-09+6,124→ 6,124 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2020-02-21+9,305→ 9,305 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Common Stock
2020-02-21$23.99/sh+5,211→ 10,211 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2019-06-18+6,124→ 6,124 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2019-02-22+12,427→ 12,427 total
Award
ARADIGM CORP
Stock Option (Right to Buy)
2018-06-29+97,323→ 97,323 total
Award
scPharmaceuticals Inc.$SCPH
Stock Option (Right to Buy)
2018-06-19+12,248→ 12,248 total
Award
SUPERNUS PHARMACEUTICALS, INC.$SUPN
Director Stock Option (Right to Buy)
2018-02-23+8,613→ 8,613 total

Companies

Recent Filings

Address

C/O SUPERNUS PHARMACEUTICALS, INC., 9715 KEY WEST AVENUE

ROCKVILLE, MD, 20850

View on SEC.gov